Trial intelligence / Profile preview

TNF and IFN-gamma in AIDS Related Complex

NCT00001004Phase 2Completed

Sponsor
National Institute of Allergy and Infectious Diseases
Modality
Gene Editing, Gene Silencing, Cytokines & Interferons
Countries
1
01

Overview

A Phase 2 trial of tumor necrosis factor-α, interferon gamma-1b in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.

02

Drugs

tumor necrosis factor-αinterferon gamma-1b
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT00001004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00001004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call